Fintel reports that on January 29, 2025, Cantor Fitzgerald upgraded their outlook for Beam Therapeutics (NasdaqGS:BEAM) from Neutral to Overweight. As of January 29, 2025, the average one-year ...

In the preceding three months, 4 analysts have released ratings for Beam Therapeutics BEAM, presenting a wide array of perspectives from bullish to bearish. The following table summarizes their ...

The USB-C is also used with a bevy of current-generation Macbooks as well as other laptop computers and electronics, making this cable a necessity for pretty much everyone, regardless of which ...

"Energy is power [multiplied by] time — so to get a given amount of energy from a beam, you either need very high power or you need to stay in the beam a long time." One such solution that was ...

Beam Therapeutics' pipeline, especially BEAM-101 for sickle cell disease, shows promise but remains in early stages with significant risks and high market expectations. Financially, BEAM has a ...

One executive order signed by Trump aims to end birthright citizenship. The executive branch has expansive authority over immigration, but many of the president’s orders are certain to face ...

Canada continues to tighten its immigration policies, and the upcoming change will affect some families of international students and foreign workers. As part of the changes announced in September ...